NO20073699L - Stabile protaglandin-inneholdende preparater - Google Patents
Stabile protaglandin-inneholdende preparaterInfo
- Publication number
- NO20073699L NO20073699L NO20073699A NO20073699A NO20073699L NO 20073699 L NO20073699 L NO 20073699L NO 20073699 A NO20073699 A NO 20073699A NO 20073699 A NO20073699 A NO 20073699A NO 20073699 L NO20073699 L NO 20073699L
- Authority
- NO
- Norway
- Prior art keywords
- protaglandin
- stable
- prostaglandin
- containing preparations
- acid ester
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Ophthalmology & Optometry (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Emergency Medicine (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0501192.9A GB0501192D0 (en) | 2005-01-20 | 2005-01-20 | Stable prostaglandin-containing compositions |
PCT/US2006/001626 WO2006078659A2 (fr) | 2005-01-20 | 2006-01-18 | Compositions stables contenant de la prostaglandine |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20073699L true NO20073699L (no) | 2007-10-19 |
Family
ID=34259405
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20073699A NO20073699L (no) | 2005-01-20 | 2007-07-17 | Stabile protaglandin-inneholdende preparater |
Country Status (16)
Country | Link |
---|---|
US (2) | US8084501B2 (fr) |
EP (1) | EP1843744A2 (fr) |
JP (2) | JP2008528490A (fr) |
KR (1) | KR20070094793A (fr) |
CN (1) | CN101106973A (fr) |
AU (1) | AU2006206649B2 (fr) |
BR (1) | BRPI0606606A2 (fr) |
CA (1) | CA2595237A1 (fr) |
CZ (1) | CZ2007555A3 (fr) |
GB (1) | GB0501192D0 (fr) |
IL (1) | IL184111A0 (fr) |
IS (1) | IS8665A (fr) |
NO (1) | NO20073699L (fr) |
NZ (1) | NZ556117A (fr) |
WO (1) | WO2006078659A2 (fr) |
ZA (1) | ZA200705428B (fr) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWI394564B (zh) * | 2006-09-21 | 2013-05-01 | Alcon Res Ltd | 自行保存型水性藥學組成物 |
EP2094839B1 (fr) | 2006-12-08 | 2020-02-05 | University of Rochester | Expansion de cellules souches hématopoïétiques |
DK2116241T3 (en) | 2007-01-26 | 2016-06-06 | Pola Pharma Inc | pharmaceutical composition |
JPWO2008096804A1 (ja) * | 2007-02-07 | 2010-05-27 | テイカ製薬株式会社 | ラタノプロスト含有点眼剤 |
JP2008247828A (ja) * | 2007-03-30 | 2008-10-16 | Wakamoto Pharmaceut Co Ltd | ラタノプロストを含有する水性医薬組成物。 |
DK2227213T3 (da) * | 2007-11-30 | 2013-01-02 | Toltec Pharmaceuticals Llc | Sammensætninger og fremgangsmåder til behandling af vaginale infektioner og patogene, vaginle biofilm |
TWI544927B (zh) | 2008-03-17 | 2016-08-11 | 愛爾康研究有限公司 | 具有低濃度的表面活性劑以促進治療劑之生物可利用性的藥學組成物 |
EP2127638A1 (fr) * | 2008-05-30 | 2009-12-02 | Santen Pharmaceutical Co., Ltd | Procédé et composition pour traiter l'hypertension oculaire et le glaucome |
WO2010016044A1 (fr) * | 2008-08-05 | 2010-02-11 | University College Cork, National University Of Ireland, Cork | Traitement de la dégénérescence de la rétine |
US20100087540A1 (en) * | 2008-10-07 | 2010-04-08 | R-Tech Ueno, Ltd. | Pharmaceutical composition |
WO2011027778A1 (fr) * | 2009-09-01 | 2011-03-10 | 株式会社アールテック・ウエノ | Composition pour une administration topique aux yeux destinée à une utilisation dans le traitement de l'hypertension oculaire et du glaucome |
US20130011354A1 (en) * | 2009-11-09 | 2013-01-10 | Allergan, Inc. | Compositions For Enhancing Hair Growth |
TWI478730B (zh) * | 2009-12-03 | 2015-04-01 | Alcon Res Ltd | 眼科乳劑 |
CN103596572A (zh) * | 2011-04-12 | 2014-02-19 | 株式会社·R-技术上野 | 水性眼用组合物 |
DE102011108948A1 (de) * | 2011-07-29 | 2013-01-31 | Achim Göpferich | Wässrige, kolloidale Lösungen von lipophilen Substanzen,insbesondere Arzneistofflösungen |
CN104208015A (zh) * | 2013-05-29 | 2014-12-17 | 天津金耀集团有限公司 | 含有曲伏前列腺素和防腐剂的眼部制剂 |
ES2747302T3 (es) * | 2015-06-09 | 2020-03-10 | Medproject Pharma Entw Und Vertriebsgesellschaft Mbh | Gel oftálmico de bimatoprost aplicable en gotas |
JP6931493B2 (ja) * | 2017-06-22 | 2021-09-08 | ヨンスン ファイン ケミカル カンパニー,リミテッド | 緑内障治療用点眼組成物 |
JP2024516834A (ja) * | 2021-04-30 | 2024-04-17 | イノベント バイオロジクス(スーチョウ)カンパニー,リミティド | Oxm3保存剤、oxm3製剤および調製方法 |
Family Cites Families (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US1366215A (en) * | 1916-08-05 | 1921-01-18 | Vaporackumulator Ab | Supplementary power plant for electric centrals |
US5165918A (en) * | 1988-06-28 | 1992-11-24 | Ciba-Geigy Corporation | Antimicrobial ophthalmic solutions containing dodecyl-dimethyl-(2 phenoxyethyl)-ammonium bromide and methods of using the same |
DE69105349T2 (de) * | 1990-05-22 | 1995-04-06 | Ueno Seiyaku Oyo Kenkyujo Kk | Behandlung von intraocularem Druck mit einer synergistischen Kombination zur ophthalmischen Verwendung. |
CA2086874E (fr) * | 1992-08-03 | 2000-01-04 | Renzo Mauro Canetta | Methodes d'administration du taxol |
US5972991A (en) * | 1992-09-21 | 1999-10-26 | Allergan | Cyclopentane heptan(ene) oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents |
AU665287B2 (en) * | 1992-12-21 | 1995-12-21 | Alcon Laboratories, Inc. | Prostaglandin combinations in glaucoma therapy |
US5510383A (en) * | 1993-08-03 | 1996-04-23 | Alcon Laboratories, Inc. | Use of cloprostenol, fluprostenol and their salts and esters to treat glaucoma and ocular hypertension |
US5545665A (en) | 1993-12-28 | 1996-08-13 | Allergan | Cyclopentane(ene) heptenoic or heptanoic acids and derivatives thereof useful as therapeutic agents |
US6011062A (en) * | 1994-12-22 | 2000-01-04 | Alcon Laboratories, Inc. | Storage-stable prostaglandin compositions |
US5631287A (en) * | 1994-12-22 | 1997-05-20 | Alcon Laboratories, Inc. | Storage-stable prostaglandin compositions |
AU7680096A (en) * | 1995-12-22 | 1997-07-17 | Alcon Laboratories, Inc. | Combinations of dp and fp type prostaglandins for lowering iop |
AR002194A1 (es) * | 1997-03-17 | 1998-01-07 | Sanchez Reynaldo Alemany | Instrumento computarizado para el analisis del movimiento. |
SE9702681D0 (sv) | 1997-07-10 | 1997-07-10 | Pharmacia & Upjohn Ab | Method and composition for treatment of impotence |
SE9702706D0 (sv) | 1997-07-11 | 1997-07-11 | Pharmacia & Upjohn Ab | Prostaglandin derivatives devoid of side-effects for the treatment of glaucoma |
WO1999012899A1 (fr) | 1997-09-09 | 1999-03-18 | The Procter & Gamble Company | Procede de production d'analogues de prostaglandine f |
US6646001B2 (en) * | 1997-12-19 | 2003-11-11 | Alcon Manufacturing, Ltd. | Use of non-steroidal anti-inflammatory agents in combination with prostaglandin FP receptor agonists to treat glaucoma and ocular hypertension |
US6235781B1 (en) * | 1998-07-14 | 2001-05-22 | Alcon Laboratories, Inc. | Prostaglandin product |
AU6132999A (en) | 1998-10-05 | 2000-04-26 | Alcon Laboratories, Inc. | Stannane synthesis of prostanoids |
US6417228B1 (en) * | 1998-11-02 | 2002-07-09 | Alcon Manufacturing, Ltd.. | 13-Aza prostaglandins for the treatment of glaucoma and ocular hypertension |
SE9900025D0 (sv) | 1999-01-08 | 1999-01-08 | Synphora Ab | Method and composition for treatment of female sexual dysfunction |
US6136846A (en) * | 1999-10-25 | 2000-10-24 | Supergen, Inc. | Formulation for paclitaxel |
JP3876355B2 (ja) * | 2000-09-13 | 2007-01-31 | 参天製薬株式会社 | 点眼液 |
US20040097592A1 (en) | 2000-09-13 | 2004-05-20 | Kenji Morishima | Eye drops |
US20030018079A1 (en) * | 2000-11-13 | 2003-01-23 | Richardson Helene | Treatment |
US6743439B1 (en) * | 2001-06-27 | 2004-06-01 | Alcon, Inc. | Ophthalmic compositions containing copolymers of sulfonated styrene and maleic anhydride |
US7351404B2 (en) * | 2002-02-04 | 2008-04-01 | Allergan, Inc. | Method of enhancing hair growth |
NO317079B1 (no) * | 2002-08-02 | 2004-08-02 | Maritime Hydraulics As | Stigerorstrekkanordning |
US6864282B2 (en) * | 2002-08-05 | 2005-03-08 | Allergan, Inc. | 9,11-cycloendoperoxide pro-drugs of prostaglandin analogues for treatment of ocular hypertension and glaucoma |
US20040076678A1 (en) * | 2002-08-21 | 2004-04-22 | Sucampo Ag | Opthalmic solution |
CA2498233C (fr) | 2002-09-09 | 2012-08-14 | Santen Pharmaceutical Co., Ltd. | Solution ophtalmique transparente contenant du latanoprost comme principe actif |
US7074827B2 (en) * | 2002-10-24 | 2006-07-11 | Sucampo Ag (Usa) Inc. | Method for treating ocular hypertension and glaucoma |
-
2005
- 2005-01-20 GB GBGB0501192.9A patent/GB0501192D0/en not_active Ceased
-
2006
- 2006-01-18 WO PCT/US2006/001626 patent/WO2006078659A2/fr active Application Filing
- 2006-01-18 NZ NZ556117A patent/NZ556117A/en not_active IP Right Cessation
- 2006-01-18 BR BRPI0606606-2A patent/BRPI0606606A2/pt not_active IP Right Cessation
- 2006-01-18 KR KR1020077016516A patent/KR20070094793A/ko not_active Application Discontinuation
- 2006-01-18 CA CA002595237A patent/CA2595237A1/fr not_active Abandoned
- 2006-01-18 AU AU2006206649A patent/AU2006206649B2/en not_active Ceased
- 2006-01-18 JP JP2007552216A patent/JP2008528490A/ja active Pending
- 2006-01-18 EP EP06718670A patent/EP1843744A2/fr not_active Withdrawn
- 2006-01-18 CN CNA2006800023897A patent/CN101106973A/zh active Pending
- 2006-01-20 US US11/336,115 patent/US8084501B2/en not_active Expired - Fee Related
-
2007
- 2007-06-21 IL IL184111A patent/IL184111A0/en unknown
- 2007-07-03 ZA ZA200705428A patent/ZA200705428B/xx unknown
- 2007-07-17 NO NO20073699A patent/NO20073699L/no not_active Application Discontinuation
- 2007-08-02 IS IS8665A patent/IS8665A/is unknown
- 2007-08-16 CZ CZ20070555A patent/CZ2007555A3/cs unknown
-
2011
- 2011-11-17 US US13/298,400 patent/US20120065258A1/en not_active Abandoned
-
2012
- 2012-12-27 JP JP2012286362A patent/JP2013056948A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
AU2006206649A1 (en) | 2006-07-27 |
US8084501B2 (en) | 2011-12-27 |
CZ2007555A3 (cs) | 2007-10-10 |
GB0501192D0 (en) | 2005-03-02 |
AU2006206649B2 (en) | 2010-05-27 |
NZ556117A (en) | 2009-10-30 |
IS8665A (is) | 2007-08-02 |
WO2006078659A2 (fr) | 2006-07-27 |
WO2006078659A8 (fr) | 2007-08-30 |
KR20070094793A (ko) | 2007-09-21 |
CA2595237A1 (fr) | 2006-07-27 |
EP1843744A2 (fr) | 2007-10-17 |
ZA200705428B (en) | 2008-09-25 |
BRPI0606606A2 (pt) | 2009-07-07 |
JP2008528490A (ja) | 2008-07-31 |
US20120065258A1 (en) | 2012-03-15 |
US20060270735A1 (en) | 2006-11-30 |
IL184111A0 (en) | 2007-10-31 |
CN101106973A (zh) | 2008-01-16 |
WO2006078659A3 (fr) | 2006-11-16 |
JP2013056948A (ja) | 2013-03-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20073699L (no) | Stabile protaglandin-inneholdende preparater | |
NO20170633A1 (no) | Forbindelser av indolamin-2,3-dioksygenase for anvendelse i behandling av kreft i kombinasjon med et anti-PD-1 antistoff . | |
EA200870019A1 (ru) | Лактамовые соединения и способы их применения | |
GT200500137A (es) | Derivados de pirrolotriazina utiles para tratar trastornos hiper-proliferativos y enfermedades asociadas con angiogenesis. | |
NO20071742L (no) | Kinazoliner som er nyttige som modulatorer av ionekanaler | |
EA200870216A1 (ru) | Амидо соединения и их применение в качестве лекарственных средств | |
NO20025601D0 (no) | Arylmetylaminderivater for anvendelse som tryptaseinhibitorer | |
ECSP10010310A (es) | Nuevos compuestos y composiciones y métodos de uso | |
NO20090157L (no) | Tienpyrimidiner anvendelige som modulatorer av ionekanaler | |
EA201001329A1 (ru) | Соединения и композиции в качестве модуляторов активности gpr119 | |
NO20080141L (no) | Indanderivater som modulatorer av ionekanaler | |
BRPI0511111A (pt) | compostos de pirrol como inibidores de cinase de proteìna de erk, sua sìntese e seus intermediários | |
EA200801492A1 (ru) | Фармацевтическое применение замещенных амидов | |
MX2022009942A (es) | Composiciones farmaceuticas que comprenden epa y un agente cardiovascular y metodos para utilizar el mismo. | |
EA201170508A1 (ru) | Производные 1-амино-2-циклобутилэтилбороновой кислоты | |
WO2007103719A3 (fr) | MODULATEURS DE LA 11-β-HYDROXYSTÉROÏDE DÉSHYDROGÉNASE DE TYPE 1, LEURS COMPOSITIONS PHARMACEUTIQUES ET LEURS PROCÉDÉS D'UTILISATION | |
NO20076447L (no) | Bicykliske derivater som modulatorer av ionekanaler | |
NO20083220L (no) | Heterocykliske derivater som modulatorer for ionekanaler | |
NO20084652L (no) | Deazapuriner anvendelige som inhibitorer av januskinaser | |
EA200700118A1 (ru) | Амидосоединения и их применение в качестве лекарственных средств | |
MY144659A (en) | 2-hydroxy-3-heteroarylindole derivatives as gsk3 inhibitors | |
NO20081975L (no) | Diarylamin-inneholdende forbindelser og sammensetninger, og deres anvendelse som modulatorer av C-kit-reseptorer | |
UA115131C2 (uk) | Сполуки боронатного ефіру і його фармацевтичні рецептури | |
MY142589A (en) | Benzimidazole derivatives : preparation and pharmaceutical applications | |
EA200800783A1 (ru) | Композиция тразодона для введения один раз в день |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |